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Differentiation(LCV) is a γ-herpesvirus closely related to Epstein–Barr virus (EBV). The rhesus
latent membrane protein 2A (LMP2A) is highly homologous to EBV LMP2A. EBV LMP2A activates the
phosphatidylinositol 3-kinase (PI3K) and β-catenin signaling pathways in epithelial cells and affects
differentiation. In the present study, the biochemical and biological properties of rhesus LMP2A in epithelial
cells were investigated. The expression of rhesus LMP2A in epithelial cells induced Akt activation, GSK3β
inactivation and accumulation of β-catenin in the cytoplasm and nucleus. The nuclear translocation, but not
accumulation of β-catenin was dependent on Akt activation. Rhesus LMP2A also impaired epithelial cell
differentiation; however, this process was not dependent upon Akt activation. A mutant rhesus LMP2A
lacking six transmembrane domains functioned similarly to wild-type rhesus LMP2A indicating that the full
number of transmembrane domains is not required for effects on β-catenin or cell differentiation. These
results underscore the similarity of LCV to EBV and the suitability of the macaque as an animal model for
studying EBV pathogenesis.
© 2008 Published by Elsevier Inc.IntroductionEpstein–Barr virus (EBV) is a γ-herpesvirus within the lympho-
cryptovirus (LCV) subgroup. EBV is the etiologic agent of infectious
mononucleosis and it is closely associated with numerous diseases
including nasopharyngeal carcinoma, Burkitt's lymphoma, Hodgkin's
disease, and numerous lymphoproliferative disorders, particularly in
immunocompromised individuals (Rickinson and Kieff, 1996). The
majority of Old World primates are naturally infected with simian
homologs of EBV. As with EBV infection in humans, infection is
ubiquitous in animals raised both in captivity and in the wild. These
simian homologs share many genetic, biologic, pathogenic, and
epidemiologic properties with human EBV. Rhesus EBV (cercopithi-
cine herpesvirus 15) can immortalize B cells in vitro (Moghaddam
et al., 1998) and has an identical genetic repertoire to EBV with an
overall sequence homology of 75% (Rivailler et al., 2002). Rhesus EBV
can also induce B-cell tumors in animals immunosuppressed due to
simian immunodeﬁciency virus infection similar to the development
of EBV induced tumors in AIDS patients (Feichtinger et al., 1992, 1990).
Recently, rhesus EBV has been shown to infect epithelial cells in
immunosuppressed macaques and can induce epithelial cell lesionsve Cancer Center, CB#7295,
e, Chapel Hill, NC 27599-7295,
lsevier Inc.that resemble oral hairy leukoplakia in AIDS patients (Kutok et al.,
2004). Additionally, a previous study has shown that rhesus macaques
experimentally infected with rhesus EBV exhibited acute and per-
sistent infections similar to EBV infection in humans, thus indicating
that rhesus macaques are a suitable animal model for EBV (Moghad-
dam et al., 1997).
These striking similarities between rhesus LCV and EBV and the 62%
amino acid similarity suggest that the molecular properties of rhesus
LMP2A (Rh-L2A) would be similar. EBV LMP2A has previously been
shown to have striking properties in epithelial cellswhere its expression
in human keratinocyte cell line, HaCaT, induced PI3K activation and the
subsequent phosphorylation and activation of Akt (Scholle et al., 2000).
In addition, HaCaT cells expressing EBV LMP2A had impaired differ-
entiationwhen grown inorganotypic raft cultures. Inhuman telomerase
immortalized human foreskin keratinocytes, HFK cells, LMP2A expres-
sion activated both the PI3K/Akt signaling andWnt/β-catenin signaling
pathways. The activation of these pathways led to the subsequent
phosphorylation and inactivation of the Akt target GSK3β. The effects
on these pathways also increased the levels and induced the nuclear
translocation of β-catenin resulting in activation of TCF mediated
transcription (Morrison et al., 2003). In HFK cells, EBV LMP2A also
inhibited epithelial cell differentiation in assays where differ-
entiation was induced by suspension in methylcellulose. In these
assays, involucrin and keratinocyte transglutaminase increase during
differentiation and these increases were blocked by EBV LMP2A
(Morrison and Raab-Traub, 2005).
Fig. 1. Expression of Rh-L2A in human foreskin keratinocytes. HFK cells were transduced with the pBabe (vector) retrovirus alone or expressing Rh-L2A. Transduced cells were placed
under puromycin selection. A) Expressionwas determined by immunoﬂuorescence using an anti-FLAG antibody. DAPI was used to visualize the nuclei. B) Immunoblot prepared with
equal amounts of protein of the Rh-L2A and Rh-L2AΔC expressing HFK cells and reacted with anti-FLAG antibody.
Fig. 2. Rh-L2A and Rh-L2AΔC phosphorylate and activate Akt in HFK cells. Cells lines
expressing Rh-L2A, Rh-L2AΔC, or vector alone were harvested, lysed, and subjected to
Western blot analysis. To detect the activated form of Akt, a phospho-speciﬁc antibody
for Ser473 was used. Total Akt was used for a loading control and densitometry with
Image J software was performed to normalize p-Akt levels to the corresponding total
Akt levels. Fold increase of the normalized p-Akt values is depicted in panel B. The ﬁgure
shown is a representative experiment from ﬁve independent experiments.
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HFK epithelial cells. Additionally, amutant Rh-L2A (Rh-L2AΔC) lacking
the C-terminal six transmembrane domains was examined. The N-
terminus of EBV LMP2A contains multiple important signaling motifs
including a src binding site, an ITAM motif, and a PY motif that is
essential for interactions with Nedd4 ubiquitin ligases. These motifs
are retained in Rh-L2A and in Rh-L2AΔC. The data presented here
indicate that both Rh-L2A and the truncation mutant induced the
phosphorylation and activation of Akt and the phosphorylation of an
Akt target, GSK3β. Rh-L2AΔC increased cytoplasmic and nuclear levels
of β-catenin and the translocation of β-catenin was blocked by
treatment with the Akt inhibitor, triciribine. In a novel differentiation
assay, Rh-L2A expressing cells had decreased levels of both involucrin.
Interestingly, loss of six transmembrane domains did not impair the
properties of Rh-L2AΔC. In addition, inhibition of Akt did not affect the
ability of LMP2A to block differentiation. These data indicate that the
rhesus homolog of EBV LMP2A behaves in a similar manner to EBV
LMP2A in epithelial cells and further validates the rhesus macaque as
an animal model for the study of EBV infection and pathogenesis in
epithelial cells.
Results
Rhesus LMP2A signaling in telomerase immortalized HFK cells activates
the PI3K/Akt pathway
EBV LMP2A has been shown to activate Akt via the PI3K pathway in
both lymphocytes and epithelial cells (Morrison et al., 2003; Scholle
et al., 2000; Swart et al., 2000). To investigate whether rhesus LMP2A
(Rh-L2A) and the C-terminus deletionmutant, Rh-L2AΔC, also activate
Akt in epithelial cells, RhL2Awas expressed inHFK cells. StableHFK cell
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or vector alone were developed, and pools of stably expressing cells
were generated after puromycin selection. Immunoﬂuorescent immu-
nohistochemistry and immunoblotting with anti-FLAG antibody
conﬁrmed the expression of FLAG-tagged Rh-L2A and Rh-L2AΔC in
the stable cell lines (Fig. 1). Immunohistochemistry staining indicated
expression in all cells. DAPI stainingof the nucleus and overlaywith the
FLAG antibody revealed that the majority of the proteinwas located at
the perinuclear membrane. Despite the loss of six transmembrane
domains, the Rh-L2AΔC mutant also localized to the perinuclear
membrane (Fig. 1A). Expression of the two forms was also identiﬁed
by immunoblotting with anti-FLAG antibody (Fig. 1B). The full-length
Rh-L2A migrated with a MW of 55 kDa, while the Rh-L2AΔC had the
appropriate MW of 42 kDa.
To detect activated Akt, Western blot analysis was performed using
a phospho-speciﬁc antibody directed against Ser473 to detect acti-
vated Akt (Fig. 2A). Both Rh-L2A and Rh-L2AΔC activated Akt to levels
higher than the pBabe control. These data indicated the similarity
with EBV LMP2A in that both Rh-L2A and Rh-L2AΔC activated Akt in
HFK cells and that the C-terminus of Rh-L2A was not required for this
function.
Akt can phosphorylate and affect the activity of many proteins
including glycogen synthase kinase beta (GSK3β) (Brazil and Hem-Fig. 3. Rh-L2A and Rh-L2AΔC reduce involucrin levels and increase levels of β-catenin
and p-GSK3β in HFK cells. HFK cells stably expressing Rh-L2A, Rh-L2AΔC, or vector
alone were harvested, lysed and subjected to Western blot analysis. A phospho-speciﬁc
antibody directed against Ser9 was utilized to detect the inactivated form of GSK3β.
Actin served as a loading control. Panel B is a graphical depiction of the quantitation
performed on the blot shown in part A and is a representative of four independent
experiments. Quantitation analysis was performed using Image J software.
Fig. 4. Rh-L2A and Rh-L2AΔC increase levels of nuclear β-catenin in HFK cells. Cells
stably expressing Rh-L2A, Rh-L2AΔC, or vector alone were harvested and fractionated
into cytosolic and nuclear components. Each component was subjected toWestern blot
analysis with antibodies to β-catenin, actin as a loading control, and GRP78 to attest to
the purity of the fractions (data not shown). Densitometry was performed with Image J
software as previously described. The fold increase of the normalized β-catenin values
are graphically depicted in panel B and this is a representative of three independent
experiments.mings, 2001). GSK3β is an important enzyme involved in regulating
glycogen storage and Wnt signaling. Phosphorylation by Akt at Ser9
inactivates GSK3β, suggesting that Akt is involved in controlling
cellular metabolism. This inactivation may affect cellular metabolism,
survival and/or cell cycle progression. Western blot analysis with
phospho-speciﬁc antibodies revealed increased phosphorylation of
GSK3β in both Rh-L2A and Rh-L2AΔC expressing cells relative to
vector control cells (Fig. 3). These data indicate that Rh-L2A expression
in HFK cells leads to the activation of Akt and subsequent phos-
phorylation and inactivation of the Akt target GSK3β and that the
C-terminus of Rh-L2A is not necessary for this function. Interest-
ingly, endogenous levels of β-catenin were increased in the Rh-L2A
expressing cells and levels of involucrin, a terminal differentiation
marker, were reduced (Fig. 3). These data further indicated the
similarity in the function of Rh-L2A with EBV LMP2A (Morrison et
al., 2003).
Rh-L2A signaling results in increased expression and nuclear
accumulation of β-catenin in HFK cells
GSK3β can bind to the axin complex and within this complex
GSK3β phosphorylates β-catenin thereby targeting it for ubiquitina-
tion and degradation via the proteosome (Novak and Dedhar, 1999).
Phosphorylation of GSK3β by Akt blocks GSK3β kinase activity,
however this GSK3β inactivation does not always affect β-catenin
accumulation and localization (Cross et al., 1995). For example, in 293
cells and CHO cells expressing insulin receptor, GSK3β inactivation
due to insulin signaling did not induce β-catenin accumulation and
activation of TCF/LEF transcription factors. However, Wnt signaling
activation did induce β-catenin accumulation and transcriptional
activationwithout inducing the phosphorylation of GSK3β (Ding et al.,
2000). Previous work from our laboratory has shown a PI3K activation
requirement for the nuclear translocation of β-catenin in HFK cells
expressing EBV LMP2A (Morrison et al., 2003). To investigate the
Fig. 5. Triciribine inhibits Akt activation in HFK cells. Stable cell lines expressing Rh-L2A,
Rh-L2AΔC, or vector alone were treated with 5 μM triciribine (TCN) for 24 h prior to
harvest. Western blot analysis was performed using antibodies to β-catenin, Akt
phosphorylated at Ser473, and GSK3β phosphorylated at Ser9.
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the status of endogenous β-catenin, a fractionation experiment was
performed with Rh-L2A and Rh-L2AΔC expressing HFK cells. Stable
cell lines expressing Rh-L2A, Rh-L2AΔC or vector alone were
fractionated and levels of β-catenin were determined by immuno-
blotting of nuclear and cytosolic extracts with an antibody directed
against β-catenin (Fig. 4). HFK cells express abundant levels of β-
catenin such that expression of Rh-L2A or Rh-L2AΔC had a minimal
effect on the cytosolic amounts of β-catenin compared with vector
alone. However, nuclear β-catenin levels were considerably increased
in the HFK cells expressing Rh-L2A and Rh-L2AΔC over cells
expressing vector alone (Fig. 4). These results indicated that Rh-L2A
and Rh-L2AΔC induce the nuclear translocation of β-catenin similarly
to that observed in EBV LMP2A expressing cells.Fig. 6. Triciribine inhibits induction of nuclear β-catenin levels in HFK cells. Cells stably ex
nuclear components 24 h post triciribine treatment. Each component was subjected to Wes
attest to the purity of the fractions (data not shown). Densitometry was performed with Im
values is graphically depicted in panel B and this is a representative of three independent eInhibition of Akt reduces expression and nuclear accumulation of
total β-catenin in Rh-L2A expressing cells
Previous studies of EBV LMP2A indicated that accumulation of total
β-cateninwas inhibited by the PI3K inhibitor, LY294002, however, the
speciﬁc requirement for Akt activationwas not determined. To further
delineate a speciﬁc requirement for activated Akt in this process and
assess the contribution of the intact transmembrane domains, the
effects of the Akt inhibitor, triciribine (TCN) were determined. A
previous study has shown that TCN is a potent and selective inhibitor
of Akt in tumor cells (Yang et al., 2004). TCN inhibits Akt by inducing a
conformational change in the molecule that prevents it from
becoming phosphorylated and phosphorylating its targets. To deter-
mine the efﬁcacy of TCN in our stable cell lines, cells expressing Rh-
L2A, Rh-L2AΔC or vector alone were treated with a 5 μM concentra-
tion of TCN or DMSO as a vehicle control. Triciribine treatment
effectively reduced the levels of phosphorylated Akt and GSK3β in all
cells conﬁrming previous work indicating that triciribine is an
effective inhibitor of Akt activation (Fig. 5) (Yang et al., 2004).
Triciribine treatment did not affect the total β-catenin levels in Rh-L2A
or Rh-L2AΔC expressing cells as compared to the vehicle control
(Fig. 5). These data conﬁrm previous studies that indicated that the
inhibition of PI3K did not signiﬁcantly affect the accumulation of
cytosolic β-catenin (Morrison et al., 2003).
Studies from our laboratory have also shown a requirement for
PI3K signaling for inducing the nuclear translocation of β-catenin by
EBV LMP2A (Morrison et al., 2003). To further investigate a speciﬁc
role for Akt activation in this process and the contribution of the intact
transmembrane domain, stable HFK cells expressing Rh-L2AΔC or
vector alone were treated with TCN or DMSO as a vehicle control
for 24 h. The cells were harvested, fractionated, and subjected to
Western blot analysis. Treatment with TCN considerably decreased
the nuclear β-catenin in the Rh-L2AΔC cells and slightly decreased the
levels in the vector control (Fig. 6). Similarly, treatment of cells ex-
pressing the full-length Rh-L2A with triciribine also inhibited nuclearpressing Rh-L2AΔC or vector alone were harvested and fractionated into cytosolic and
tern blot analysis with antibodies to β-catenin, actin as a loading control, and GRP78 to
age J software as previously described. The fold increase of the normalized β-catenin
xperiments.
Fig. 8. Rh-L2A inhibition of involucrin expression is not Akt dependent. HFK cells stably
expressing Rh-L2A or vector alone were untreated or treated with triciribine (TCN) for
24 h. Cell lysates were analyzed by Western blotting.
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that the deletion of six transmembrane domains in Rh-L2AΔC did not
affect this property of Rh-L2A as both full-length and Rh-L2AΔC
induced nuclear translocation of β-catenin and this process speciﬁ-
cally required activation of Akt.
Rh-L2A inhibits differentiation in HFK cells
Previous studies have shown that EBV LMP2A blocks activation of B
cells through the B-cell receptor and also can inhibit epithelial cell
differentiation that is induced when HaCaT cells are grown in
organotypic raft cultures (Scholle et al., 2000). Differentiation of HFK
cells induced by growth in methylcellulose was also blocked as
evidenced by decreased involucrin (Morrison and Raab-Traub, 2005).
To test other methods of inducing differentiation, cells were plated in
Petri dishes containing DMEM media instead of regular keratinocyte
media. This has been shown to induce differentiation by impairing cell
attachment and increasing calcium levels in a similar fashion to
previously described methods (Alfandari et al., 1999). To further
characterize the effects of Rh-L2A and Rh-L2AΔC expressions on
differentiation and to determine the efﬁcacy of this method for the
induction of differentiation, HFK cells expressing Rh-L2A, Rh-L2AΔC
or vector alone were grown in Petri dishes with standard DMEM
media to induce differentiation and subsequently analyzed for
involucrin expression. During growth in regular keratinocyte media,
the Rh-L2A and Rh-L2AΔC expressing cells had decreased levels of
involucrin as compared to the control cells (Fig. 7A). Upon the
induction of differentiation, involucrin expression increased approxi-
mately 3 fold in the control cells. In comparison, involucrin levels were
remained considerably lower in both Rh-L2A and Rh-L2AΔC expres-
sing cells with an increase in involucrin of approximately 40% (Fig. 7B).
These data indicate that Rh-L2A expression negatively regulates dif-
ferentiation in HFK cells in a similar manner to EBV LMP2A. Further-
more, these data conﬁrm that the C-terminus of Rh-L2A is not
required for LMP2A mediated inhibition of differentiation.
As inhibition of Akt effectively blocked the nuclear translocation of
β-catenin, it was of interest to assess the contribution of Akt activationFig. 7. Rh-L2A inhibits differentiation in HFK cells. Stable cells expressing Rh-L2A, Rh-
L2AΔC, or vector alone were plated in Petri dishes containing standard DMEM media.
48 h post-seed, cells were harvested and lysates were analyzed by Western blot. The
induction of differentiation was ascertained using an antibody directed against
involucrin, a marker of terminal differentiation. Actin was used as a loading control.
Panel B shows the fold increase of involucrin after differentiation normalized to actin
and vector control cells at zero time. Involucrin levels were determined by Image J
software and are representative of ﬁve independent experiments.to the effects of LMP2A on markers of differentiation. Interestingly, in
cells that have not been induced to differentiate, treatment with
triciribine did not affect the ability of Rh-L2A or Rh-L2AΔC to inhibit
expression of the differentiation marker, involucrin. Triciribine
reduced levels of involucrin in both control and Rh-L2A cells (Fig. 8).
These data suggest that the effects of Rh-L2A and Rh-L2AΔC on
differentiation markers do not require activation of Akt.
Discussion
This study reveals that the rhesus homolog of the EBV LMP2A
protein has similar properties and can affect both the PI3K/Akt and
Wnt/β-catenin signaling pathways in telomerase immortalized HFK
cells. Expression of both Rh-L2A and Rh-L2AΔC in HFK cells induced
the phosphorylation and activation of Akt and subsequent phosphor-
ylation and inactivation of the Akt target, GSK3β. With the inactiva-
tion of GSK3β, β-catenin accumulated in the cytoplasm and
translocated into the nucleus. The nuclear translocation of β-catenin
was dependent on Akt activation and the inhibition of Akt by
triciribine blocked this effect (Fig. 6). Previous work in our laboratory
had shown a requirement for PI3K activation for the nuclear
translocation of β-catenin, but not for cytosolic accumulation
(Morrison et al., 2003). The data presented here reveal that the
requirement for PI3K is likely mediated by its effects on Akt.
The present study also indicates that Rh-L2A blocks epithelial cell
differentiation. Previous work from our laboratory has shown a similar
role for EBV LMP2A in both HFK and HaCaT cell lines (Morrison et al.,
2003; Scholle et al., 2000). Importantly, the data presented here clearly
indicate that the loss of six of the twelve transmembrane domains does
not affect the ability of Rh-L2A to activate the PI3K/Akt pathway or
inhibit epithelial cell differentiation. This likely reﬂects the retention of
the signaling motifs within the cytoplasmic N-terminus of both
proteins. The N-terminus of both Rh-L2A and EBV LMP2A contain PY
and ITAM motifs which are involved in many functions of the protein.
The two proline rich PY motifs are known to interact with members of
the Nedd4 family of ubiquitin ligases such as AIP4 and Itch in B cells
(Ikeda et al., 2003). Through the ITAM motif the PI3K/Akt pathway is
activated and LMP2 associates with Syk kinase in B cells (Fruehling and
Longnecker, 1997; Swart et al., 2000). Additionally, the ITAM and PY
motifs are involved in PI3K/Akt and β-catenin signaling in epithelial
cells (Morrisonet al., 2003; Scholle et al., 2001). The datapresentedhere
conﬁrm that these properties of LMP2A require the motifs at the N-
terminus but do not require the full complement of transmembrane
domains. The transmembrane domains are thought to contribute to
oligomerization and constitutive signaling. Previously, the contribution
of the LMP2 transmembrane domains to B-lymphocytes immortaliza-
tionwas assessed using genetically engineered EBV. Deletion of the last
seven transmembrane or ﬁrst ﬁve transmembrane spanning domains
did not impair B-cell immortalization by EBV (Longnecker et al., 1993a,
b). The data presented here indicate that six transmembrane domains
are also sufﬁcient for the effects of Rh-L2A in epithelial cells.
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nuclear accumulation of β-catenin in NPC clinical samples and NPC
xenografts (Morrison et al., 2004). Infection of epithelial cells by the
rhesus LCV has also been detected in immunosuppressed macaques
(Kutok et al., 2004). SIV infected, immunosuppressed LCV infected
macaques also develop B-cell lymphomas and oral lesions resembling
oral hairy leukoplakia (Habis et al., 1999; Kutok et al., 2004). The data
presented here suggest that Rh-L2A may also contribute to these
pathologies.
In summary, these data indicate that Rh-L2A can phosphorylate
and activate Akt, phosphorylate and inactivate GSK3β, enable
accumulation and nuclear translocation of β-catenin, and inhibit
differentiation in epithelial cells. The activation of Akt is critical for
the nuclear accumulation and translocation of β-catenin but is not
required for the inhibition of differentiation by of Rh-L2A and Rh-
L2AΔC. Importantly, this study also reveals that at least six trans-
membrane domains that are deleted in Rh-L2AΔC are not required for
these properties. These data prove analogous properties of EBV LMP2A
and Rh-L2A and further validate the rhesus macaque model for the
study of EBV pathogenesis.
Materials and methods
Cell culture and retrovirus
Human foreskin keratinocytes (HFK) immortalized with human
telomerase (Farwell et al., 2000) were cultured in serum-free
keratinocyte media (K-SFM, Gibco) supplemented with 2 ng/ml of
epidermal growth factor, 30 μg/ml bovine pituitary extract, and 1%
antibiotic–antimycotic solution (Gibco). 293Tcells weremaintained in
Dulbecco's modiﬁed Eagle medium (DMEM, Gibco) supplemented
with 10% FBS and 1% antibiotic–antimycotic solution. Both HFK and
293T cells were grown at 37 °C in a humidiﬁed incubator with 5% CO2.
To create stable cell lines, recombinant retroviruses expressing either
vector alone (pBabe) or vector subcloned with FLAG-tagged rhesus
LMP2A (pBabe-Rh-L2A) were generated as previously described using
FuGene 6 transfection reagent (Roche) according to manufacturer's
instructions and used to transduce HFK cells (Scholle et al., 2000).
Pools of stable cells expressing either pBabe, pBabe-Rh-L2A, or pBabe-
Rh-L2AΔC were selected for in the presence of 0.5 μg/ml puromycin
(Sigma).
Lysate preparation and cellular fractionations
Whole cell lysates were prepared using Nonidet P-40 (NP-40) lysis
buffer containing 50 mM Tris–HCl, 150 mM NaCl, 2 mM EDTA, 10%
glycerol, 1% NP-40, 1 mM sodium vanadate (Na3VO4), 0.4 mM
phenylmethylsulfonyl ﬂuoride (PMSF), and protease and phosphatase
cocktails (Sigma) at 1:100. Cellular fractionations were performed
using OptiPrep (Sigma) according to a modiﬁed manufacturer's
protocol. In brief, cells were resuspended in buffer A (20 mM HEPES,
10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 1 mM
Na3VO4, 0.5 mM PMSF, and protease and phosphatase inhibitor
cocktails at 1:100) with 1% NP-40. Crude nuclei were pelleted at
1000 rpm and cytosolic fractions were extracted. Nuclei were puriﬁed
over an OptiPrep gradient with 25, 30, and 35% layers and then lysed
with a hypotonic buffer (20 mM Tris–HCl, 400 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 25% glycerol, 1 mM Na3VO4, 0.5 mM PMSF, and
protease and phosphatase inhibitor cocktails at 1:100).
Differentiation assays
To set up the assay, approximately 4×106 HFK cells expressing Rh-
L2A, Rh-L2AΔC, or vector alone were plated in 100 mm Petri dishes
containing keratinocyte media and placed at 37 °C overnight. The
keratinocyte media were then removed and replaced with DMEM andplaced again at 37 °C for 48 h. After the incubation period, cells were
harvested and cell pellets were then lysed using Nonidet P-40 (NP-40)
lysis buffer containing 50mMTris–HCl,150mMNaCl, 2mMEDTA,10%
glycerol, 1% NP-40, 1 mM sodium vanadate (Na3VO4), 0.4 mM
phenylmethylsulfonyl ﬂuoride (PMSF), and protease and phosphatase
cocktails (Sigma) at 1:100.
Inhibitor experiments
For fractionation and zero time experiments (cells not induced to
differentiate), HFK cells were plated in either 100 mm or 150 mm
dishes containing keratinocyte media. Within 24 h post-seed,
triciribine (TCN) was added to the media at a concentration of 5 μM.
Control plates were treated with an equivalent volume of DMSO
(vehicle control). After 24 h of inhibitor treatment, cells were
harvested and lysates were generated for Western blot analysis. For
differentiation experiments, HFK cells were plated in 100 mm Petri
dishes containing standard DMEMmedia to induce differentiation. At
24 h post-seed, TCN was added to the media at a concentration of
5 μM. DMSO was used as a vehicle control. At 24 h post-treatment
(48 h into the induction of differentiation), cells were harvested and
lysates were generated for Western blot analysis.
Western blot analysis and antibodies
Protein concentrations were determined using the Bio-Rad DC
assay system according to manufacturer's instructions. Lysates were
boiled in a protein loading solution containing SDS and β-mercap-
toethanol for 5 min and subjected to SDS-10% polyacrylamide gel
electrophoresis. Proteins were transferred to an Optitran nitrocellu-
lose membrane (Schleicher & Schuell) and subjected to Western blot
analysis. Antibodies used include anti-involucrin antibody from
Sigma; anti-Akt, anti-phospho-Akt Ser473 and anti-phospho-GSK3β
from Cell Signaling; anti-actin from Santa Cruz; and anti-β-catenin
from Transduction Laboratories. Horseradish peroxidase secondary
antibodies (Amersham) and SuperSignal West Pico System (Pierce)
were used to detect antibody bound proteins.
Immunoﬂuorescence
HFK cells expressing pBabe, Rh-L2A, or Rh-L2AΔCwere plated in six
well plates containing a coverslip. Approximately 24 h post-seed, the
cells were ﬁxed with 4% paraformaldehyde for 15 min at RT. Cells were
then washed 3× with PBS and anti-FLAG antibody (Sigma) or DAPI
(Molecular Probes)was applied as speciﬁedby themanufacturer. Again,
cells were washed 3× with PBS and a FITC-conjugated anti-mouse
secondaryantibody (Jackson ImmunoResearch)was addedaccording to
manufacturer's instructions. Cells were then washed 3× with PBS and
mounted on coverslips using an anti-fade mounting medium.
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